James Brady
Director/Board Member bij VERONA PHARMA PLC
Vermogen: - $ op 31-03-2024
Profiel
James Brady is an Independent Non-Executive Director at Verona Pharma Plc and a Director at Panavance Therapeutics, Inc. He was previously the Chief Financial Officer at MedImmune Ltd.
from 2013 to 2018.
He holds an MBA from Drexel University and an undergraduate degree from St. Joseph University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VERONA PHARMA PLC
-.--% | 29-04-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van James Brady
| Bedrijven | Functie | Begin |
|---|---|---|
| VERONA PHARMA PLC | Director/Board Member | 14-03-2022 |
| Panavance Therapeutics, Inc. | Director/Board Member | - |
Eerdere bekende functies van James Brady
| Bedrijven | Functie | Einde |
|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Director of Finance/CFO | 01-01-2018 |
Opleiding van James Brady
| Drexel University | Masters Business Admin |
| St. Joseph University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VERONA PHARMA PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Panavance Therapeutics, Inc. |
